This indicates that MCC alteration may not be a driver (but rather a passenger) of colorectal tumorigenesis, and we hypothesize that its disruption in human CRCs could merely be a result of its close proximity to APC in the human genome (Figures 2 &4), as rationalized as follows. The gene discussed is APC; the disease is medical procedure.